We are live on ! Find out more
RNVA

Rennova Health, Inc.
RNVA

Delisted

RNVA was delisted on the 24th of October, 2017.

9 hedge funds and large institutions have $161K invested in Rennova Health, Inc. in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

44% less funds holding

Funds holding: 169 (-7)

56% less capital invested

Capital invested by funds: $362K → $161K (-$201K)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
9
Holders Change
-7
Holders Change %
-43.75%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
8
Calls
Puts
Net Calls
Net Calls Change

RNVA Hedge Fund Activity: Q1 2017 in Review

9 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q1 2017, worth a combined $161K — down 56% from $362K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of RNVA and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, adding an estimated $103K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $97K sold.

  • 9 institutional investors held Rennova Health, Inc. (RNVA) as of Q1 2017, down from 16 in Q4 2016.
  • Funds reported $161K of Rennova Health, Inc. stock for Q1 2017, down 56% quarter-over-quarter.
  • 3 funds opened new Rennova Health, Inc. positions in Q1 2017 and 8 closed out, a net change of -5 holders.
  • The largest Rennova Health, Inc. buyer in Q1 2017 was Morgan Stanley, an estimated $103K added.
  • The largest Rennova Health, Inc. seller in Q1 2017 was Virtu KCG Holdings, an estimated $97K sold.

Based on aggregated 13F filings for Q1 2017.